Castle Biosciences (CSTL) Insider Trading & Ownership $32.33 +1.18 (+3.79%) (As of 11:08 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Castle Biosciences (NASDAQ:CSTL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$5.04 M Get CSTL Insider Trade Alerts Want to know when executives and insiders are buying or selling Castle Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CSTL Insider Buying and Selling by Quarter Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade Castle Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/14/2024Derek J MaetzoldInsiderSell1,972$32.27$63,636.44 10/8/2024Derek J MaetzoldInsiderSell986$30.27$29,846.22 10/7/2024Daniel BradburyDirectorSell7,867$29.44$231,604.48 10/4/2024Derek J MaetzoldInsiderSell986$28.73$28,327.78 8/12/2024Daniel BradburyDirectorSell7,883$26.65$210,081.95 8/7/2024Frank StokesCFOSell10,000$25.70$257,000.00 Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover8/1/2024Kristen M OelschlagerCOOSell12,989$23.06$299,526.34 7/29/2024Kristen M OelschlagerCOOSell2,793$22.06$61,613.58 6/3/2024Derek J MaetzoldInsiderSell2,368$23.40$55,411.20 5/6/2024Daniel BradburyDirectorSell23,323$24.64$574,678.72 5/6/2024Derek J MaetzoldInsiderSell2,368$24.72$58,536.96 4/23/2024Derek J MaetzoldInsiderSell421$20.11$8,466.31 4/12/2024Derek J MaetzoldInsiderSell1,947$20.35$39,621.45 4/8/2024Daniel BradburyDirectorSell2,400$20.45$49,080.00 4/4/2024Daniel BradburyDirectorSell9,152$21.45$196,310.40 4/3/2024Derek J MaetzoldInsiderSell2,368$21.70$51,385.60 3/20/2024Derek J MaetzoldInsiderSell2,295$20.27$46,519.65 3/7/2024Derek J MaetzoldInsiderSell2,372$20.77$49,266.44 3/5/2024Derek J MaetzoldInsiderSell4,131$21.41$88,444.71 3/4/2024Daniel BradburyDirectorSell23,323$20.68$482,319.64 2/7/2024Daniel BradburyDirectorSell2,074$23.20$48,116.80 1/4/2024Daniel BradburyDirectorSell18,223$20.40$371,749.20 12/28/2023Derek J MaetzoldInsiderSell3,954$22.17$87,660.18 12/26/2023Derek J MaetzoldInsiderSell5,180$21.93$113,597.40 12/22/2023Derek J MaetzoldInsiderSell5,224$21.96$114,719.04 12/20/2023Derek J MaetzoldInsiderSell5,201$21.05$109,481.05 12/18/2023Derek J MaetzoldInsiderSell5,720$20.27$115,944.40 12/12/2023Daniel BradburyDirectorSell1,200$20.01$24,012.00 12/12/2023Derek J MaetzoldInsiderSell546$20.01$10,925.46 12/8/2023Daniel BradburyDirectorSell6,875$20.09$138,118.75 12/8/2023Derek J MaetzoldInsiderSell2,322$20.10$46,672.20 12/6/2023Daniel BradburyDirectorSell200$20.02$4,004.00 12/6/2023Derek J MaetzoldInsiderSell48$20.02$960.96 12/4/2023Daniel BradburyDirectorSell4,340$20.08$87,147.20 12/4/2023Derek J MaetzoldInsiderSell1,379$20.08$27,690.32 12/1/2023Daniel BradburyDirectorSell9,545$20.05$191,377.25 12/1/2023Derek J MaetzoldInsiderSell3,235$20.06$64,894.10 11/29/2023Daniel BradburyDirectorSell17,342$20.12$348,921.04 11/29/2023Derek J MaetzoldInsiderSell5,743$20.13$115,606.59 11/24/2023Daniel BradburyDirectorSell800$20.02$16,016.00 Top 10 AI Stocks to Buy Now (Ad)Are you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.Download our free report today11/24/2023Derek J MaetzoldInsiderSell287$20.03$5,748.61 11/20/2023Daniel BradburyDirectorSell5,755$20.04$115,330.20 (Data available from 1/1/2013 forward) CSTL Insider Trading Activity - Frequently Asked Questions Who is on Castle Biosciences's Insider Roster? The list of insiders at Castle Biosciences includes Daniel Bradbury, Derek J Maetzold, Ellen Goldberg, Frank Stokes, Kristen M Oelschlager, and Tiffany Olson. Learn more on insiders at CSTL. What percentage of Castle Biosciences stock is owned by insiders? 7.20% of Castle Biosciences stock is owned by insiders. Learn more on CSTL's insider holdings. Which Castle Biosciences insiders have been buying company stock? The following insiders have purchased CSTL shares in the last 24 months: Ellen Goldberg ($69,024.00), and Tiffany Olson ($24,983.00). How much insider buying is happening at Castle Biosciences? Insiders have purchased a total of 5,962 CSTL shares in the last 24 months for a total of $94,007.00 bought. Which Castle Biosciences insiders have been selling company stock? The following insiders have sold CSTL shares in the last 24 months: Daniel Bradbury ($5,446,373.60), Derek J Maetzold ($2,125,209.35), Frank Stokes ($257,000.00), and Kristen M Oelschlager ($361,139.92). How much insider selling is happening at Castle Biosciences? Insiders have sold a total of 373,519 Castle Biosciences shares in the last 24 months for a total of $8,189,722.87 sold. Castle Biosciences Key ExecutivesMr. Derek J. Maetzold (Age 62)Founder, CEO, President & Director Compensation: $1.45M4 recent tradesMr. Frank Stokes (Age 53)CFO & Treasurer Compensation: $849.36k1 recent tradesMs. Kristen M. Oelschlager R.N. (Age 56)Chief Operating Officer Compensation: $782.7k2 recent tradesMr. Tobin W. Juvenal (Age 64)Chief Commercial Officer Compensation: $782.7kCamilla ZuckeroVice President of Investor Relations & Corporate AffairsMs. Alice Bahner IzzoSenior Vice President of MarketingMr. Kevin DomanVice President of SalesMs. Keli GreenbergVP of Human Resources & Executive Director of Human ResourcesDr. Robert W. Cook Ph.D. (Age 52)Senior Vice President of Research & Development Dr. Matthew Goldberg M.D.Senior Vice President of Medical More Insider Trading Tools from MarketBeat Related Companies MYGN Insider Transactions BTSG Insider Transactions GH Insider Transactions VCYT Insider Transactions LFST Insider Transactions ADUS Insider Transactions WGS Insider Transactions PRVA Insider Transactions NHC Insider Transactions FTRE Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors This page (NASDAQ:CSTL) was last updated on 11/6/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s Spending Plans Are Here (Here's What You Must Know)Trump's back in the White House, but here's what they're not telling you: his plans could cause inflation to s...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSTL Stock Alerts